Limited User Release of the Company’s Next-Generation InSet® Glenoid Implant Follows Successful Completion of First Surgical Case GRAND RAPIDS, Mich., Oct. 8, 2026 — Shoulder

Second Product Introduction on New Line of Technologies for Metal-Sensitive Patients GRAND RAPIDS, Mich., Sept. 10, 2026 — Shoulder Innovations, Inc. (“Shoulder Innovations”, or “the

GRAND RAPIDS, Mich., Sept. 9, 2026 — Shoulder Innovations, Inc. (“Shoulder Innovations”, or “the company”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on

GRAND RAPIDS, Mich., Sept. 8, 2026 — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder

GRAND RAPIDS, Mich., Sept. 1, 2026 — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on